To ask the Secretary of State for Health and Social Care, how many prescriptions for medical cannabis have been issued on the NHS since the rescheduling of cannabis-based products.
Cannabis-based products for medicinal use were rescheduled on 1 November 2018 to allow clinicians on the General Medical Council’s ‘Specialist Register’ to prescribe cannabis-based products for medicinal use, where clinically appropriate and in the best interest of patients.
NHS England and NHS Improvement is using extant systems to monitor use of the newly rescheduled unlicensed cannabis-based products for medicinal use in England. In England, these systems monitor the number of items dispensed and associated costs in primary care and the volume of products used and associated cost in secondary care. NHS England’s and NHS Improvement’s Controlled Drug Accountable Officers are also collecting local intelligence in both the National Health Service and independent sector.